Vaccine production seen helping Nigeria beyond COVID

The project, to cost $51 million, is estimated to span between five and seven years

Nigeria’s bid to establish its own COVID-19 vaccine production plant could serve as a catalyst to research and produce vaccines for other endemic diseases beyond the current needs of the pandemic, analysts have said. It could become re-purposed to fight other life-threatening infectious disease

```

Members Only

Login or create an account to continue

This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.

New to BusinessDay? Register now and start reading.

```